AI News about pharmaceutical acquisition

Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders

Lilly Acquires Centessa to Expand Sleep Disorder Pipeline Eli Lilly is acquiring Centessa Pharmaceuticals in a strategic move to advance its portfolio of sleep-wake disorder treatments. The clinical-stage company brings novel therapeutics that complement Lilly's existing neuroscience pipeline. This acquisition strengthens Lilly's position in the growing sleep medicine market.